Data Demonstrated Nasal Delivery of INP105 (POD-olanzapine) Achieved Peak Olanzapine Plasma Levels Twice as Fast as Intramuscular Injection, Ten-Times Faster than Orally-Disintegrating Tablets
Study Showed a Safety and Tolerability Profile Consistent with Currently Marketed Formulations of Olanzapine.